Ganga Pharmaceuticals
Ganga Pharmaceuticals Share Price Chart
Ganga Pharmaceuticals last traded at ₹12.50 (2026-10-13). Over the past month the stock moved +0.0%, three months the stock moved +4.2%, year the stock moved -15.5%. Its closing range over 52 weeks is ₹11.68 – ₹13.97, with the latest close 10.5% below the high.
Closing prices up to 2026-10-13.
About Ganga Pharmaceuticals
Incorporated in 1989, Ganga Pharmaceuticals Ltd manufactures & trades in Pharmaceuticals & allied products (Ayurveda)[1]
Business Overview:[1] GPL is engaged in production of quality Ayurvedic Medicines. Apart from manufacturing, the company is also into marketing and distribution of Ayurvedic Medicines
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Ganga Pharmaceuticals reported sales of ₹1.46 crore (+2.8%) and net profit of ₹0.08 crore (+166.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1.46 | 0.07 | 4.79 | 0.08 | 0.14 |
| Sep 2025 | 1.37 | -0.02 | -1.46 | 0.02 | 0.03 |
| Mar 2025 | 1.33 | 0.00 | 0.00 | 0.06 | 0.12 |
| Sep 2024 | 1.31 | -0.11 | -8.40 | 0.02 | 0.04 |
| Mar 2024 | 1.42 | 0.01 | 0.70 | 0.03 | 0.06 |
| Sep 2023 | 1.32 | 0.05 | 3.79 | 0.02 | 0.05 |
| Mar 2023 | 1.23 | -0.07 | -5.69 | 0.01 | 0.02 |
| Sep 2022 | 1.35 | 0.07 | 5.19 | 0.03 | 0.07 |
| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +18.4% | +0.0% | +5.6% | +14.5% | -3.0% | +8.1% | +3.8% | +2.8% |
| Operating profit growth | +0.0% | – | +150.0% | +0.0% | -257.1% | – | -140.0% | +600.0% |
| Net profit growth | +50.0% | – | – | +0.0% | -33.3% | +500.0% | +0.0% | +166.7% |
| EPS growth | +40.0% | – | – | -14.3% | -42.9% | +500.0% | -40.0% | +133.3% |
| OPM % | 5.2% | -5.7% | 3.8% | 0.7% | -8.4% | 0.0% | -1.5% | 4.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Ganga Pharmaceuticals reported sales of ₹2.83 crore (+7.2%) and net profit of ₹0.10 crore (+25.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2.83 | 0.04 | 1.41 | 0.10 | 0.17 |
| Mar 2025 | 2.64 | -0.12 | -4.55 | 0.08 | 0.17 |
| Mar 2024 | 2.74 | 0.05 | 1.82 | 0.05 | 0.10 |
| Mar 2023 | 2.47 | 0.00 | 0.00 | 0.04 | 0.10 |
| Mar 2022 | 2.32 | 0.04 | 1.72 | 0.04 | 0.10 |
| Mar 2021 | 2.27 | 0.03 | 1.32 | 0.02 | 0.05 |
| Mar 2020 | 2.99 | 0.38 | 12.71 | 0.19 | 0.47 |
| Mar 2019 | 3.18 | 0.42 | 13.21 | 0.19 | 0.47 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +16.5% | -6.0% | -24.1% | +2.2% | +6.5% | +10.9% | -3.6% | +7.2% |
| Operating profit growth | +31.3% | -9.5% | -92.1% | +33.3% | -100.0% | – | -340.0% | – |
| Net profit growth | +111.1% | +0.0% | -89.5% | +100.0% | +0.0% | +25.0% | +60.0% | +25.0% |
| EPS growth | +113.6% | +0.0% | -89.4% | +100.0% | +0.0% | +0.0% | +70.0% | +0.0% |
| OPM % | 13.2% | 12.7% | 1.3% | 1.7% | 0.0% | 1.8% | -4.6% | 1.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Ganga Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Ganga Pharmaceuticals.
Frequently Asked Questions
What is the share price of Ganga Pharmaceuticals today?
Ganga Pharmaceuticals shares were last quoted at ₹12.50 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Ganga Pharmaceuticals?
Ganga Pharmaceuticals has a price-to-earnings (P/E) ratio of 73.53 and a price-to-book (P/B) ratio of 0.89. The industry P/E is 53.45.
What is the 52-week high and low of Ganga Pharmaceuticals?
The 52-week high of Ganga Pharmaceuticals is ₹13.97 and the 52-week low is ₹9.35.
What is the market cap of Ganga Pharmaceuticals?
The market capitalisation of Ganga Pharmaceuticals is about ₹7.39 crore.
How did Ganga Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Mar 2026), Ganga Pharmaceuticals reported sales of ₹1.46 crore (+2.8%) and net profit of ₹0.08 crore (+166.7%), compared with the same quarter last year.
Is Ganga Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Ganga Pharmaceuticals has a 3-year ROE of 1.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Ganga Pharmaceuticals?
Promoters hold about 50.91% of Ganga Pharmaceuticals.
Which sector does Ganga Pharmaceuticals belong to?
Ganga Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.